Knowles D M, Jakobiec F A
Cancer. 1980 Aug 1;46(3):576-89. doi: 10.1002/1097-0142(19800801)46:3<576::aid-cncr2820460326>3.0.co;2-d.
Sixty cases of orbital lymphoid neoplasms originally accessioned as malignant lymphomas were analyzed histopathologically and the follow-up data evaluated separately for each category as follows: inflammatory pseudo-tumor, 5; reactive lymphoid hyperplasia, 8; atypical lymphoid hyperplasia, 7; and malignant lymphocytic lymphoma (classified according to Rappaport), 40. Significant clinical differences were not observed among these patients, suggesting that the lesions must be distinguished by histologic rather than clinical criteria. Systematic application of the histologic criteria discussed here improved diagnostic accuracy and our ability to predict clinical outcome as substantiated by follow-up data. Two of 13 patients (15%) with benign pseudo-lymphomas, 2 of 7 patients (29%) with atypical lymphoid hyperplasia, 2 of 8 patients (25%) with well differentiated lymphocytic lymphomas, and 22 of 32 patients (68%) with less differentiated lymphocytic lymphomas either had or later developed systemic lymphomas. Thus, the degree of cytologic differentiation appears to be the single most important factor for determining the prognosis of patients with orbital lymphoid neoplasms.
对最初诊断为恶性淋巴瘤的60例眼眶淋巴样肿瘤进行了组织病理学分析,并对以下每一类别的随访数据进行了单独评估:炎性假瘤5例;反应性淋巴样增生8例;非典型淋巴样增生7例;恶性淋巴细胞淋巴瘤(根据Rappaport分类)40例。这些患者之间未观察到显著的临床差异,这表明必须通过组织学而非临床标准来区分病变。如随访数据所证实的,系统应用本文讨论的组织学标准提高了诊断准确性以及我们预测临床结果的能力。13例良性假淋巴瘤患者中有2例(15%)、7例非典型淋巴样增生患者中有2例(29%)、8例高分化淋巴细胞淋巴瘤患者中有2例(25%)以及32例低分化淋巴细胞淋巴瘤患者中有22例(占68%)已发生或后来发展为全身性淋巴瘤。因此,细胞学分化程度似乎是决定眼眶淋巴样肿瘤患者预后的唯一最重要因素。